UNLIMITED
Episode 38 by Biotech Hangoutratings:
Length:
60 minutes
Released:
Nov 7, 2022
Format:
Podcast episode
Description
In this episode, Daphne, Bruce, Tim and guest Jefferies’ Michael Yee discuss the latest happenings in biotech, including recent key earnings, clinical data including ASH abstracts, “BAMG (Bristol Myers Squibb, Amgen, Merck and Gilead) as the new FAANG” and ways that companies are navigating the current challenging financing environment including debt, royalties, reverse mergers & the idea of returning capital after a setback. The episode also delves into the healthy follow-on financing environment.
Released:
Nov 7, 2022
Format:
Podcast episode
Titles in the series (89)
- 57 min listen